RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Share Data

Home  >  Investor Relations  >  Stock Information  >  Share Data

Listings in the U.S. and Europe

QIAGEN’s common shares have been registered and traded in the United States since 1996, listing on the New York Stock Exchange effective January 10, 2018, after trading on NASDAQ markets since the initial public offering (IPO). The shares have traded in Germany on the Frankfurt Stock Exchange since 1997, and the Prime Standard segment since its launch in 2003. Dual listing on NYSE and the Frankfurt exchange offers advantages for QIAGEN, our shareholders and employees since global presence increases the potential market opportunity and enhances liquidity. Unlike American Depositary Receipts (ADRs), QIAGEN shares provide equal corporate rights for all shareholders and can be traded on either exchange, in U.S. dollars or euros.

NYSE (effective January 10, 2018) / NASDAQ (until January 9, 2018) 2020 2019 2018
Year-end price $52.85 $33.80 $34.45
High $55.27 $43.16 $39.45
Low $32.97 $25.04 $30.78
Average daily trading volume (in million shares) 1.59 1.56 0.99
Frankfurt Stock Exchange (XETRA) 2020 2019 2018
Year-end price €42.45 €30.46 €29.68
High €46.95 €39.19 €34.05
Low €29.55 €22.54 €25.22
Average daily trading volume (in million shares) 0.91 0.60 0.53

Index Membership

QIAGEN is a constituent in various European, U.S. and global stock indices, some of which serve as benchmarks or investment universes for mutual funds and exchange traded funds. QIAGEN ranks as one of the leading components by market capitalization in Germany’s TecDAX index, which includes the 30 largest German technology companies not in the benchmark DAX index. Effective September 24, 2018, QIAGEN is also a member of MDAX, which includes the 60 largest comapnies in Germany after the 30 largest companies included in the DAX. QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. QIAGEN shares also are included in other stock market indexes such as the MSCI Europe, EMU and EAFE indexes.

Key share data 2020 2019 2018
Total equity (in $ thousands) 2,797,839 2,536,591 2,634,970
Issued shares (in thousands) 230,829 230,829 230,829
Outstanding shares at December 31 (in thousands) 227,985 227,752 225,509
Weighted-average number of common shares outstanding - basic (in thousands) 228,427 226,777 226,640
Weighted-average number of common shares outstanding - diluted (in thousands) 234,214 226,777 233,456
Year-end market capitalization (in $ million) 12,049 7,698 7,769
Year-end market capitalization (in € million) 9,678 6,937 6,693
Free Float (in %) 99.37 98.34 97.19